RE:RE:RE:RE:RE:Everyone take a breath and relaxI think MedX is in a difficult space as a public company. The larger brokerage firms will not pay attention to MedX as there are no corporate fees to be had and the smaller brokerage firms are bottom feeders and more transactional in nature.They don't have real distribution. So MedX is in investor purgatory but I do not believe for long. MedX needs more investor eyeballs on the story and it needs a new shareholder audience to move the share price significantly.
So how can MedX achieve this goal?
It needs to attract a few credible microcap managers and in order to do this MedX will need to be cashflow positive. That answers your continous dilution issue as well as your debt repayment issue. I think what you will see over the next few months is MedX rolling out into additional countries as well as making a big inroad into the US market. That will allow MedX to become cashflow positive in short order and have a new US audience to tell the story to.I believe a lot of these initiatives are in place so I am expecting a strong news flow in the first quarter.
Timing on the Brazilian deal? According to the press release the large purchase order came from their Brazilian partners in anticipation of regulatory clearance. This is the largest order in MedX's history so it was MATERIAL and MedX would have had to release this information to shareholders in a timely matter according to OSC/TSX rules. In the press release the Brazilian partners noted they were expecting regulatory clearance shortly and given they are working directly with ANVISA the regulatory body I expect they would have a sense on the timing. They also indicated they had been doing a lot of pre-marketing in Brazil with great success and had developed a stong backlog of orders pending regulatory approval. I think this is just the Brazilian partners getting out ahead of the approval so they can satisfy demand. I do strongly believe tis is just a starting order and Brazil will be a major revenue contributor to MedX this year.
Hope this helps